MedTrace Logo

Metastatic Tumor Research and Outcomes Network

NCT02830451 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 960

Last updated 2026-02-25

No results posted yet for this study

Summary

The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

Conditions

  • Metastatic Spine Tumor

Sponsors & Collaborators

  • AO Foundation, AO Spine

    collaborator OTHER

  • AO Innovation Translation Center

    lead OTHER

Principal Investigators

  • Charles G. Fisher, MD · Vancouver General Hospital and the University of British Columbia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-15
Primary Completion
2026-08-15
Completion
2026-08-15

Countries

  • United States
  • Australia
  • Canada
  • Germany
  • Hungary
  • Italy
  • Japan
  • Netherlands
  • Singapore
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830451 on ClinicalTrials.gov